Michal Lebl

Title: Michal Lebl: Innovator in Peptide Synthesis and Vasopressin Analogues

Introduction

Michal Lebl is a prominent inventor based in Praha, Czech Republic. He has made significant contributions to the field of peptide synthesis and vasopressin analogues. With a total of 5 patents to his name, Lebl's work has advanced the understanding and application of these compounds in medical science.

Latest Patents

Lebl's latest patents include the development of analogues of 8-D-homoarginine vasopressin. These analogues were prepared with a general formula where X can be various amino acids, and R is either cysteine or β-mercaptopropionic acid. The vasopressin analogues exhibited an increased affinity to uterus receptors for oxytocin, acting as oxytocin antagonists. Additionally, the analogues of deamino vasopressin showed significantly reduced antidiuretic activity compared to [8-D-arginine]vasopressin. Another notable patent is an apparatus for performing multiple synthesis of peptides on a solid carrier. This apparatus allows for the successive bonding of active components to functional groups anchored on a carrier, which comprises a planar porous material divided into functionalized compartments.

Career Highlights

Throughout his career, Michal Lebl has worked with esteemed institutions such as the Czechoslovak Academy of Sciences and the Academy of Sciences of the Czech Republic. His innovative approaches to peptide synthesis have garnered attention in the scientific community.

Collaborations

Lebl has collaborated with notable colleagues, including Jutta Eichler and Vit Pokorny, contributing to various research projects and advancements in his field.

Conclusion

Michal Lebl's contributions to the field of peptide synthesis and vasopressin analogues highlight his role as an influential inventor. His patents and collaborations continue to impact medical research and applications.